Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy.
Department of Medicine - DIMED, University hospital, Padova, Italy.
Serena
S
Granziera
Department of Thrombosis and Haemostasis, Guy's and St Thomas' Hospitals, London, UK.
Alexander T
AT
Cohen
D000925:Anticoagulants / Q000008:administration & dosage*; D000991:Antithrombins / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D054556:Venous Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000008:administration & dosage*; D015091:beta-Alanine / Q000031:analogs & derivatives*
D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin
Accident & Emergency Medicine